What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
Sustained abstinence is currently the only accepted end-point for pharmacotherapy trials for most substance use disorders (SUD), with the exception of alcohol. Despite recent efforts, the identification of a non-abstinence alternative as a clinically meaningful end-point for drug use trials has been...
Saved in:
| 主要作者: | |
|---|---|
| 其他作者: | |
| 格式: | Journal Article |
| 語言: | 英语 |
| 主題: | |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!